Kinesin inhibitor marches toward first-in-class pivotal trial

Nat Med. 2013 Dec;19(12):1550. doi: 10.1038/nm1213-1550a.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Pharmacological / analysis
  • Clinical Trials as Topic
  • Humans
  • Kinesin / antagonists & inhibitors*
  • Kinesin / physiology
  • Molecular Targeted Therapy / methods
  • Neoplasms / drug therapy*
  • Pilot Projects
  • Thiadiazoles / therapeutic use*
  • Tubulin Modulators / therapeutic use*

Substances

  • ARRY 520
  • Antineoplastic Agents
  • Biomarkers, Pharmacological
  • KIF11 protein, human
  • Thiadiazoles
  • Tubulin Modulators
  • Kinesin